Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...

Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...

In the randomized, controlled Phase III trial, children will receive either a single injection of ETX101 or be assigned to a sham control group.

In oncology drug development, using biomarkers to select a study population more likely to benefit from a therapeutic effect is critical to increase the efficiency of a clinical trial in demonstrating ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

This landmark study, often called the "Nürnberger Kochsalzversuch", is historically significant as probably the first recorded instances of a randomized, double-blind, placebo-controlled trial. It was ...